NSE - Delayed Quote INR
Caplin Point Laboratories Limited (CAPLIPOINT.NS)
1,806.70
-77.70
(-4.12%)
At close: April 25 at 3:30:01 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
3,183,900
2,713,700
3,367,300
2,686,100
Investing Cash Flow
--
-3,200,400
-2,175,800
-3,767,700
-294,400
Financing Cash Flow
--
-380,700
-281,700
-406,800
-239,800
End Cash Position
--
1,387,000
1,775,600
1,507,600
4,311,100
Capital Expenditure
--
-1,458,200
-1,934,700
-911,800
-733,300
Issuance of Capital Stock
--
100
200
300
--
Free Cash Flow
--
1,725,700
779,000
2,455,500
1,952,800
3/31/2021 - 6/23/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABBOTINDIA.NS Abbott India Limited
29,705.00
-1.18%
MANKIND.NS Mankind Pharma Limited
2,557.50
-1.60%
SUVENPHAR.NS Suven Pharmaceuticals Limited
1,143.20
-5.11%
ERIS.NS Eris Lifesciences Limited
1,468.20
-2.90%
NATCOPHARM.BO NATCO Pharma Limited
889.65
-1.55%
IPCALAB.NS Ipca Laboratories Limited
1,419.00
-1.85%
FREDUN.BO Fredun Pharmaceuticals Limited
667.40
-3.23%
SUVENPHAR.BO Suven Pharmaceuticals Limited
1,143.25
-5.12%
CIPLA.NS Cipla Limited
1,525.90
-1.66%
LINCOLN.NS Lincoln Pharmaceuticals Limited
593.20
-1.09%